1 – 14 of 14
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Neuroendocrine abnormalities in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK
(
- Contribution to journal › Article
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
(
- Contribution to journal › Article
- 2015
-
Mark
Anticholinergic Load : Is there a Cognitive Cost in Early Parkinson's Disease?
(
- Contribution to journal › Article
- 2014
-
Mark
The Central Clock in Patients With Parkinson Disease — Reply
(
- Contribution to journal › Letter
-
Mark
Sleep and circadian rhythm regulation in early Parkinson disease
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article